Our Science

Cancer Immunology and In Vivo Imaging


Immune Microenvironment

in Cancers

In Vivo Imaging

Drug Development


[Cancer Immunology]

In recent years, oncology research has seen immense progress due to the development of cancer immunology. Our lab has contributed to this revolution by discovering the vital role of myeloid cells in the tumor microenvironment, a previously unexplored area. We are currently leading the task of unveiling the immense potential of myeloid cells in cancers.​

Relevant Papers

Jeong et al., 2021, Immune Network.

Jeong et al., 2019, Frontiers in Immunol.

Jung et al., 2017, Proc Natl Acad Sci U S A.

Jung et al., 2017, J Clin Invest.

[In Vivo Imaging]

Furthermore, our lab utilizes intravital multi-photon microscopy to examine "real-life phenomena" that cannot be seen through conventional methods. With this state-of-the-art tool, we are able to conduct novel research by observing biological processes in living organisms, thus setting us apart from other labs.

Relevant Papers

Choo et al., 2020, BMB Reports.

Jung et al., 2017, J Clin Invest.

Jung et al., 2013, Circ Res.

Recombinant Protein Engineering

siRNA delivery using nanoparticles

[Drug Development]

The aforementioned use of cutting-edge imaging platforms allows us to delve into cancer immunology.

Our lab is interested in not only nurturing the basic sciences, but also advancing clinical research through drug development. Collaboration with the plethora of competent clinical doctors on campus will lead us to this end, especially in the field of translational medicine.

Relevant Papers

Lee et al., 2021, Chem. Mater.

Jung et al., 2017, Proc Natl Acad Sci U S A.

Jung et al., 2017, J Clin Invest.

Jung et al., 2011, J Biol Chem.


cancer immunology, in vivo imaging, single-cell genomics, vascular biology, tumor microenvironment, intravital multi-photon microscopy, drug development